you're constantly mystified by what your little one can do Every achievement is a source of pride and amazement: baby's first time sitting up on his own Kathy Bradshaw has been the editor of Chatter magazine and is also responsible for putting out the Chatter and Get Out newsletters weekly She was previously executive editor of Where Y’at magazine in New Orleans and received multiple Press Club awards for her work on that publication She got her master’s degree in professional writing at the University of New Orleans When not writing about everything from monkeys to mahjong Kathy likes to swim in weird bodies of water and speak French This document may not be reprinted without the express written permission of Chattanooga Times Free Press Material from the Associated Press is Copyright © 2025 audio and/or video material shall not be published rewritten for broadcast or publication or redistributed directly or indirectly in any medium Neither these AP materials nor any portion thereof may be stored in a computer except for personal and noncommercial use The AP will not be held liable for any delays errors or omissions therefrom or in the transmission or delivery of all or any part thereof or for any damages arising from any of the foregoing When I was working on this exhibition my hero was Nicholas Sprimont, a goldsmith who went on to create the first porcelain factory in England. Sprimont is not just some mysterious character creating gorgeous bits of silver; we know some things about him. He came from Liège and worked with the Huguenot goldsmiths in London His wife said he was able to draw and model well and there are even some surviving drawings attributed to him (now in the V&A) When you see this group of objects on the table all together you realise what dinners with Frederick would have been like – with the candlelight flickering on the gilding bringing these works to life and the food itself adding to the artistry of the whole thing Nicholas Sprimont left the world of metalwork for the new venture of a porcelain factory at Chelsea – surely a high risk venture in the days when no English factory had achieved success at creating porcelain I love the early works from the factory now in the exhibition – charming tureens in the shape of cauliflowers and bunches of asparagus (what's not to love?) and plates painted with multi-coloured insects and plants They were obviously having fun with their new product and how can we not admire Sprimont for getting on with it he was the one who wrote to the government asking them to stop importing foreign porcelain so that the English could have a chance Sprimont even set up a school for local boys to teach them how to draw you can see Sprimont's imagination in overdrive – drawing inspiration from the world around him and leaving an amazing legacy that's fun and colourful and beautiful all at the same time Kathryn Jones is curator of decorative arts, Royal Collection Trust. She is a curator of the exhibition The First Georgians: Art and Monarchy 1714-1760 (2014) and the author of "For the Royal Table: Dining at the Palace (2008)". With the ongoing displacement of millions worldwide, two publications remind us of the value in welcoming victims fleeing war and persecution, alongside the global nature of those populations—whether transitory or permanent, past and present—who have called the UK haven and home. Medicine bottle (1700-1800), found in the City of London by Mudlark’d author Malcolm Russell Matthew Williams-Ellis • Tessa Murdoch, Europe Divided: Huguenot Refugee Art & Culture,V&A, 320pp, 250 colour illustrations, £40/$55 (hb), published UK 9 December 2021 and US 18 January 2022 • Malcolm Russell, Mudlark’d: Hidden Histories from the River Thames, Thames & Hudson, 223pp, 417 colour illustrations, £25 (hb), published 28 April 2022 • Jacqueline Riding is Books Editor at The Art Newspaper archive1 December 1997Ceramics: Blue and white, all right!A round-up of some recent books on porcelain news1 June 2015The powerful presence of Rubens in every ageTheodore K Rabb looks at the Flemish artist’s “legacy” over nearly four centuries Their symbiotic relationship is the subject of a new book can also be found just a few kilometers from Brussels Ah, waterfalls offer real moments suspended in time. In Sprimont, near Liège, the path known as the “Croix Verte” (parking lot at the start of Comblain-au-Pont) winds through the countryside until it reaches the magnificent Cascade de Chanxhe. The entire 10 km loop takes 3 hours to complete. You can shorten your walk by parking upstream from Rue du Pont (in which case, don’t hesitate to visit the ruins of Château de Fays). 📍Address: Rue de Picopré 4140, 4140 Sprimont. Park upstream from Ovifat or Longfaye, and walk over several small wooden bridges to reach the splendid Cascade du Bayehon. The waterfall ends its course in a large pool surrounded by rock faces, giving it its distinctive, photogenic color. The Fagne du Setay nature reserve, where the waterfall is located, abounds in trails. The complete loop (for the most courageous) is 12.6 km long. Are you in good shape? 📍Address: Chemin de la Cascade, 4950 Malmedy. Observe this waterfall’s long, winding path through the rocks: you can clearly see how the passage of water has carved the rock over the years. Or even centuries! The Reinhardstein waterfall is truly impressive in its height! Although the trail isn’t the most accessible (some of the bridges are barely secured, so be careful), the walk has one huge advantage: the magnificent Château de Reinhardstein overlooking the waterfall! 📍Address: Rue de Bosfagne 11-7, 4950 Waimes. The Cascade de la Chaudière (two streams flowing into the same basin) is astonishing: one of its tributaries seems to meander horizontally between the rocks! This walk along the Ninglinspo is one of the most beautiful you can do in the Belgian Ardennes, and is particularly easy to access for the whole family (allow 6-7 km for the total walk). If you’re looking for peace and quiet in the middle of nature, you can forget all about the Cascades de Coo! Surrounded by the village of the same name, the Plopsa Coo amusement park, a campsite and the Coo-Adventure sports park, they are probably the most touristic (and noisy) waterfalls in Belgium. But their sheer size is impressive (although beware of the water flow, which can be very dangerous). A road bridge crosses them. From the mouth of the stream to its arrival in the basin, the Cascade de Haldeboeuf spreads over an impressive 50-meter drop. What’s even more surprising is that a staircase takes you up and down the various levels – but there are no barriers or safety features, so be careful! Please note: the waterfall is not visible in all weathers and seasons, and there is sometimes little or no water, often in autumn. 📍Address: Chem. de la Halte des Boeufs, 4910 Theux. Volume 12 - 2021 | https://doi.org/10.3389/fphar.2021.625699 Despite ample evidence for the therapeutic potential of inhibition of the cystine/glutamate antiporter system xc− in neurological disorders and in cancer none of the proposed inhibitors is selective a lot of research has been performed using the EMA- and FDA-approved drug sulfasalazine (SAS) Even though this molecule is already on the market for decades as an anti-inflammatory drug serious side effects due to its use have been reported Whereas for the treatment of the main indications SAS needs to be cleaved in the intestine into the anti-inflammatory compound mesalazine it needs to reach the systemic circulation in its intact form to allow inhibition of system xc− The higher plasma levels of intact SAS (or its metabolites) might induce adverse effects independent of its action on system xc− Some of these effects have however been attributed to system xc− inhibition calling into question the safety of targeting system xc− In this study we chronically treated system xc− - deficient mice and their wildtype littermates with two different doses of SAS (160 mg/kg twice daily or 320 mg/kg once daily i.p.) and studied some of the adverse effects that were previously reported SAS had a negative impact on the survival rate the thermoregulation and/or stress reaction of mice of both genotypes and thus independent of its inhibitory action on system xc− While SAS decreased the total distance travelled in the open-field test the first time the mice encountered the test it did not influence this parameter on the long-term and it did not induce other behavioral changes such as anxiety- or depressive-like behavior no major histological abnormalities were observed in the spinal cord we were unable to identify any undesirable system xc−-dependent effect of chronic administration of SAS have been valuable tools to identify the involvement of system xc− in disease progression in preclinical settings xCT−/− mice have been shown to be protected in models for several neurological disorders and studied the welfare of the mice as well as different behavioral outcomes Given inconsistent reports on the use of SAS in disorders characterized by deficits in the spinal cord such as MS we further focused on the involvement of system xc− in possible toxic effects of chronic SAS treatment on the spinal cord Six-month-old male xCT−/- and xCT+/+ littermates were used. These mice are high-generation descendants (more than 15 back-crosses on a C57BL/6 J background) of the strain originally described by Sato et al. (2005) Mice were genotyped by a PCR amplification on DNA extracted from ear punches using the REDExtract-N-Amp Tissue PCR kit (Sigma-Aldrich) and the following primers: 5”‐GATGCCCTTCAGCTCGATGCGGTTCACCAG‐3“(GFPR3); 5”‐CAGAGCAGCCCTAAGGCACTTTCC‐3“(mxCT5” flankF6); 5”‐CCG​ATG​ACG​CTG​CCG​ATG​A TGATGG‐3”(mxCT [Dr.4]R8) Mice were group-housed under standardized conditions (20–24°C 45–65% humidity) with free access to water and food Animal experiments were approved by the Ethical Committee for Animal Experiments of the Vrije Universiteit Brussel and carried out according to the national guidelines on animal experimentation All efforts were made to minimize animal suffering the body weight of each animal was measured every week to adjust the dose of SAS Starting from the second week of treatment effects of SAS on locomotor function and anxiety-like behavior were analyzed using the open field (OF) test 2 h after the first injection of the day (12:00 a.m.) we evaluated the effect of SAS on body temperature (immediately after the first injection of the day) as well as depressive-like behavior using the mouse tail suspension test (MTS we included a wash-out period of one week during which the mice did not receive SAS or saline injections and studied the long-lasting effects of SAS on body weight locomotor function and anxiety-like behavior (using the OF as well as the elevated plus maze (EPM) test) mice were sacrificed by cervical dislocation and spinal cord was harvested and post-fixed in 4% paraformaldehyde for 72 h mice were acclimatized to the testing room at least 1 h prior to assessment and all analyses were performed by a researcher blinded for treatment and genotype Graphical illustration of the experimental design the body weight of the mice was measured and starting from the second week of treatment effects of SAS on locomotor function and anxiety-like behavior were analyzed using the open field test (OF) we evaluated the effect of SAS on body temperature as well as depressive-like behavior using the mouse tail suspension test long-lasting effects of SAS on body weight locomotor function and anxiety-like behavior (using the OF as well as the elevated plus maze test) were studied mice were sacrificed and the spinal cord was harvested for further analysis In the OF, mice were placed in a corner of a square box (60 × 60 × 60 cm) with surrounding black opaque walls that prevent observation of visual cues outside the arena (Bentea et al., 2015) The center of the arena was defined as the central 40 × 40 cm zone The illuminance in the arena was 150 lux in the center and 30 lux in the corners Mice were allowed to explore the arena for 5 min and the experiment was video-recorded The total distance travelled (parameter for spontaneous locomotion and explorative behavior) as well as the cumulative duration spent in the center zone (parameter for anxiety-like behavior) were analyzed using an automated video tracking system (Ethovision software In the EPM, mice were placed in the corner of a closed arm of an elevated (37 cm from the ground) cross-shaped maze consisting of two open and two enclosed arms (32.5 cm length × 6 cm width × 17 cm height), with a center area of 6 × 6 cm (Rodgers et al., 1995) Mice were allowed to explore the maze for 5 min and the experiment was video-recorded The time spent in the open arms (parameter for anxiety-like behavior) the total distance travelled and velocity (parameters to evaluate locomotor functions) were analyzed using an automated video tracking system (Ethovision software) The body temperature of the mice was recorded before as well as 10 ADinstruments) connected to a thermometer (Testo 935 The post-fixed spinal cords were embedded in paraffin sliced into 10 µm sections using a microtome mounted on glass slides and dried overnight at 42°C Slides containing sections of the cervical region of the spinal cord were soaked in Eriochrome Cyanine (Sigma-Aldrich) for 30 min and after rinsing with deionized water slides were processed in a bath of differentiator (ammonium hydroxide) Counterstaining was performed with Neutral Red (Thermo Scientific) Stained sections were examined using a Leica 2450 microscope (Leica Microsystems Gmbh) Primary antibodies used for immunostaining Data are presented as mean ± standard error of the mean (SEM) we evaluated the effect of SAS treatment in each genotype separately a two-way ANOVA followed by a Sidak's multiple comparisons test (MCT) comparing each dose of SAS to the saline group or a Wilcoxon matched-pairs signed rank test (Wilcoxon MSRT) was used a Kruskal-Wallis (KW) test was performed followed by a Dunn’s MCT comparing each dose of SAS to the saline group Categorical data was analyzed using a Fisher's exact test and survival curves were analyzed using a Log-rank test All analyses were performed in GraphPad Prism eight and the α-value was set at 0.05 The effect of chronic sulfasalazine (SAS) treatment on survival and body weight Survival curves of xCT+/+ (n = 10–14 mice/group) (A) and xCT−/− mice (n = 11–15 mice/group) (B) were determined using a Kaplan-Meier curve and analyzed with a Log-rank test Body weight of xCT+/+ (n = 10–14 mice/group at the start of the experiment n = 8–11 mice/group after four weeks of treatment) (C) and xCT−/− mice (n = 11–15 mice/group at the start of the experiment n = 10–11 mice/group after four weeks of treatment) (D) was recorded weekly and plotted as the change compared to baseline (i.e Data are presented as mean ± SEM and analyzed using a two-way ANOVA followed by a Sidak's multiple comparisons test for each dose of SAS compared to saline ###p < 0.001: for treatment effect over all timepoints; $p < 0.05: for treatment effect at one specific timepoint SAS320 over the entire period of testing: p = 0.0694) In line with the treatment effect of 160 mg/kg of SAS in xCT+/+ mice this effect is mostly seen at week 2 of the treatment (Sidak’s MCT The effect of chronic sulfasalazine (SAS) treatment on locomotor function as well as anxiety- and depressive-like behavior The total distance travelled in the open field (OF) test was used to measure locomotor function of xCT+/+ (n = 10–14 mice/group at the start of the experiment n = 8–11 mice/group after four weeks of treatment) (A) and xCT−/− mice (n = 11–12 mice/group at the start of the experiment n = 10–11 mice/group after four weeks of treatment) (B) starting from the second week of treatment The cumulative duration spent in the center of the OF arena was plotted to study anxiety-like behavior (C,D) The immobility-time in the mouse tail suspension test (MTS) performed after four weeks of treatment was assessed as a parameter for depressive-like behavior (n = 7–10 xCT+/+mice/group (E); n = 10 xCT−/− mice/group (F)) Data are presented as mean ± SEM and analyzed using a two-way ANOVA followed by Sidak's multiple comparisons for each dose of SAS compared to saline for the OF: ##p < 0.01 ###p < 0.001: for treatment effect over all timepoints; $p < 0.05 $$$p < 0.001: for treatment effect at one specific timepoint MTS data were analyzed using a Kruskal-Wallis test xCT+/+ mice: p = 0.7696 xCT−/− mice: p = 0.4688) The effect of chronic sulfasalazine (SAS) treatment on changes in body temperature after injection 60 and 120 min after SAS injection and plotted as absolute values (A,B) or as the difference compared to the body temperature before injection (C,D) (n = 9–10 x CT+/+ mice/group (A,C); n = 10–11 xCT−/− mice/group (B,D)) Data are presented as mean ± SEM and analyzed using a Wilcoxon matched-pairs signed rank test for each treatment paradigm at the different timepoints compared to baseline (A–B): saline: *p < 0.05 **p < 0.01; SAS160: #p < 0.05 ##p < 0.01; SAS320: $$p < 0.01 A Kruskal-Wallis test (C-D; **p < 0.01 ***p < 0.001 ****p < 0.0001) followed by Dunn’s multiple comparison was used to compare each dose of SAS to saline on each timepoint (###p < 0.001 ####p < 0.0001) Long-term effects of chronic sulfasalazine (SAS) treatment body weight of xCT+/+(A) and xCT−/− mice (B) was evaluated and plotted as the change compared to baseline (i.e Distance travelled in the open field (OF) arena (C,D) or the elevated plus maze (EPM) (E,F) and velocity while exploring the EPM (G,H) were evaluated and represent long-term effects on locomotor function J) or in the open arms of the EPM (K,L) was used as a parameter for anxiety-like behavior n = 8–10 xCT+/+ mice/group and n = 10–11 xCT−/− mice/group were used Data are presented as mean ± SEM and analyzed using a Kruskal-Wallis test (*p < 0.05) followed by Dunn’s multiple comparisons for each dose of SAS compared to saline (##p < 0.01) xCT+/+ mice: p = 0.2231 xCT−/− mice: p = 0.4807) these results demonstrate that chronic SAS treatment did not induce long-term changes in motor function or anxiety-like behavior Four weeks of treatment with either 160 mg/kg or 320 mg/kg of SAS did not induce any histological abnormalities in the spinal cord of xCT+/+ or xCT−/− mice (Figure 6A). Also NeuN quantification did not show any significant effect of SAS treatment on the number of neurons present in the gray matter of the spinal cord (Figures 6B–D; KW test xCT+/+: p = 0.4600 xCT−/−: p = 0.9523) Histological examination of the spinal cord of mice after chronic sulfasalazine (SAS) treatment Representative photomicrographs of the eriochrome cyanine/neutral red staining (A) as well as the NeuN immunohistochemistry (B) A higher magnification picture of the boxed area in (B) is shown in (C) NeuN+ cells were quantified using the Cell Sens software (D) One slice of n = 3–5 mice/group was used data are presented as mean ± SEM and analyzed using a Kruskal-Wallis test followed by Dunn’s multiple comparisons for each dose of SAS compared to saline Post-hoc analysis revealed significantly lower levels of MAG immunoreactivity in the spinal cord of xCT−/− mice treated with 320 mg/kg of SAS compared to saline-treated mice (Dunn’s MTC Effects of chronic sulfasalazine (SAS) treatment on oligodendrocytes in the spinal cord Representative photomicrographs (A) and quantification (B,C) of p25α immunostaining to analyze oligodendrocytes Effects of chronic sulfasalazine (SAS) treatment on myelin in the spinal cord Representative photomicrographs of myelin basic protein (MBP) (A) and myelin-associated glycoprotein (MAG) immunostaining (B) as well as quantification of the MAG staining (C,D) One slice of n = 3–7 mice/group was used data are presented as mean ± SEM and analyzed using a Kruskal-Wallis test (*p < 0.05) followed by Dunn’s multiple comparisons for each dose of SAS compared to saline (#p < 0.05) Effects of chronic sulfasalazine (SAS) treatment on astrocytes and microglia in the spinal cord Representative photomicrographs of GFAP immunohistochemical staining (A) The extent of astrogliosis (normal (0) or presence of slight (1) mild (2) or severe astrogliosis (3)) was quantified in xCT+/+(B) and xCT−/−(C) mice Data are presented as mean ± SEM and analyzed using a Fisher's exact test to compare normal GFAP staining (score 0) with signs of astrogliosis (scores 1–3) for each dose of SAS compared to saline Representative photomicrographs of Iba-1 immunohistochemical staining after a wash-out period of one week (D) One slice of n = 4–7 mice/group (for GFAP) or n = 5–11 mice/group (for Iba-1) was used we are confident that none of these effects are mediated via chronic inhibition of this transporter this might abolish the PGE2-induced hyperthermia As this is entirely hypothetical and cannot fully explain the hypothermic reaction after chronic SAS treatment this phenomenon requires further investigation SAS did not cause abnormalities in the spinal cord making it unlikely that the effect on the distance walked in the OF results from toxicity on spinal motor pathways this effect disappeared after a wash-out period of one week the fact that mice treated with SAS travelled significantly less compared to saline injected mice the first time they perform the OF test is most probably not reflecting a motor problem but rather linked to motivation to explore the maze we showed that treatment of xCT−/− mice with 320 mg/kg of SAS induced a decreased time spent in the center of the OF which would indicate an anxiogenic effect of SAS in these mice that is independent of system xc− this study emphasizes the need for further research in this area to allow safe targeting of system xc− in diverse neurological disorders and cancer types The raw data supporting the conclusions of this article will be made available by the authors The animal study was reviewed and approved by the Ethical Committee for Animal Experiments of the Vrije Universiteit Brussel CN and AM analyzed and interpreted data; LV and AM wrote the manuscript; all authors discussed the results This work was supported by a grant of the Medical Foundation Queen Elisabeth (GSKE Wetenschappelijk Fonds Willy Gepts of the UZBrussel and a Strategic Research Program of the Vrije Universiteit Brussel (SRP40/49 OL and LP are supported by the Fund for Scientific Research Flanders (FWO The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest We kindly thank Frank Van Der Kelen and Ellen Swinnen (Vrije Universiteit Brussel Belgium) for their help and technical assistance This research was made possible thanks to the access to the microscope facility of the “PlateformeTechnologique Morphologie–Imagerie”(Université de Namur) 1https://www.clinicaltrials.gov/ct2/show/NCT04205357?term=sulfasalazine&draw=2&rank=1 Genetic Deletion of xCT Attenuates Peripheral and Central Inflammation and Mitigates LPS-Induced Sickness and Depressive-like Behavior in Mice PubMed Abstract | CrossRef Full Text | Google Scholar Absence of System Xc- in Mice Decreases Anxiety and Depressive-like Behavior without Affecting Sensorimotor Function or Spatial Vision PubMed Abstract | CrossRef Full Text | Google Scholar Amino Acid Transporters in Cancer and Their Relevance to "glutamine Addiction": Novel Targets for the Design of a New Class of Anticancer Drugs PubMed Abstract | CrossRef Full Text | Google Scholar Regional Oligodendrocytopathy and Astropathy Precede Myelin Loss and Blood-Brain Barrier Disruption in Murine Model of Osmotic Demyelination Syndrome PubMed Abstract | CrossRef Full Text | Google Scholar Slc7a11 Gene Controls Production of Pheomelanin Pigment and Proliferation of Cultured Cells PubMed Abstract | CrossRef Full Text | Google Scholar Inhibition of Cystine Uptake Disrupts the Growth of Primary Brain Tumors PubMed Abstract | CrossRef Full Text | Google Scholar Sulfasalazine Aggravates Experimental Autoimmune Encephalomyelitis and Causes an Increase in the Number of Autoreactive T Cells CrossRef Full Text | Google Scholar In Search of a Depressed Mouse: Utility of Models for Studying Depression-Related Behavior in Genetically Modified Mice PubMed Abstract | CrossRef Full Text | Google Scholar Chemotherapeutic xCT Inhibitors Sorafenib and Erastin Unraveled with the Synaptic Optogenetic Function Analysis Tool PubMed Abstract | CrossRef Full Text | Google Scholar a Cystine-Glutamate Transporter Induces Apoptosis and Tumor Regression for KSHV/HIV-associated Lymphoma PubMed Abstract | CrossRef Full Text | Google Scholar Adverse Reactions during Salicylazosulfapyridine Therapy and the Relation with Drug Metabolism and Acetylator Phenotype PubMed Abstract | CrossRef Full Text | Google Scholar Loss of System X(c)- Does Not Induce Oxidative Stress but Decreases Extracellular Glutamate in hippocampus and Influences Spatial Working Memory and Limbic Seizure Susceptibility PubMed Abstract | CrossRef Full Text | Google Scholar Slc7a11 (xCT) Protein Expression Is Not Altered in the Depressed Brain and System Xc- Deficiency Does Not Affect Depression-Associated Behaviour in the Corticosterone Mouse Model PubMed Abstract | CrossRef Full Text | Google Scholar Capsazepine Block of Voltage-Activated Calcium Channels in Adult Rat Dorsal Root Ganglion Neurones in Culture PubMed Abstract | CrossRef Full Text | Google Scholar System xc- and Glutamate Transporter Inhibition Mediates Microglial Toxicity to Oligodendrocytes CrossRef Full Text | Google Scholar Sulfasalazine-induced Cystine Starvation: Potential Use for Prostate Cancer Therapy PubMed Abstract | CrossRef Full Text | Google Scholar Side Effects of Control Treatment Can Conceal Experimental Data when Studying Stress Responses to Injection and Psychological Stress in Mice PubMed Abstract | CrossRef Full Text | Google Scholar Effects of Acute and Chronic Stressors and CRF in Rat and Mouse Tests for Depression PubMed Abstract | CrossRef Full Text | Google Scholar Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination PubMed Abstract | CrossRef Full Text | Google Scholar Blockade of ALK4/5 Signaling Suppresses Cadmium- and Erastin-Induced Cell Death in Renal Proximal Tubular Epithelial Cells via Distinct Signaling Mechanisms CrossRef Full Text | Google Scholar a Potent Suppressor of Lymphoma Growth by Inhibition of the X(c)- Cystine Transporter: a New Action for an Old Drug PubMed Abstract | CrossRef Full Text | Google Scholar Improving the Practicality of Using Non-aversive Handling Methods to Reduce Background Stress and Anxiety in Laboratory Mice CrossRef Full Text | Google Scholar Prognostic Significance of Adverse Events in Patients with Hepatocellular Carcinoma Treated with Sorafenib CrossRef Full Text | Google Scholar Disruption of xCT Inhibits Cell Growth via the ROS/autophagy Pathway in Hepatocellular Carcinoma PubMed Abstract | CrossRef Full Text | Google Scholar Chronic and Acute Effects of Stress on Energy Balance: Are There Appropriate Animal Models? PubMed Abstract | CrossRef Full Text | Google Scholar Weight Loss in Rats Exposed to Repeated Acute Restraint Stress Is Independent of Energy or Leptin Status PubMed Abstract | CrossRef Full Text | Google Scholar Suppression of the SLC7A11/glutathione axis Causes Synthetic Lethality in KRAS-Mutant Lung Adenocarcinoma PubMed Abstract | CrossRef Full Text | Google Scholar Effects of Chronic Restraint Stress on Body Weight PubMed Abstract | CrossRef Full Text | Google Scholar The Role of Mesalamine in the Treatment of Ulcerative Colitis PubMed Abstract | Google Scholar Amino Acid Transporter SLC7A11/xCT at the Crossroads of Regulating Redox Homeostasis and Nutrient Dependency of Cancer PubMed Abstract | CrossRef Full Text | Google Scholar and Intraperitoneal Injection of Saline on Behavior of Mice in an Elevated Plus-Maze PubMed Abstract | CrossRef Full Text | Google Scholar Anticonvulsant and Antiepileptogenic Effects of System Xc− Inactivation in Chronic Epilepsy Models PubMed Abstract | CrossRef Full Text | Google Scholar The Cystine/glutamate Antiporter System X(c)(-) in Health and Disease: from Molecular Mechanisms to Novel Therapeutic Opportunities PubMed Abstract | CrossRef Full Text | Google Scholar Cystine-glutamate Antiporter xCT as a Therapeutic Target for Cancer PubMed Abstract | CrossRef Full Text | Google Scholar Inhibits Nicotinic Acetylcholine Receptors in Rat Trigeminal Ganglia PubMed Abstract | CrossRef Full Text | Google Scholar Potential Use of the Anti-inflammatory Drug CrossRef Full Text | Google Scholar The X(c)- Cystine/glutamate Antiporter: a Potential Target for Therapy of Cancer and Other Diseases PubMed Abstract | CrossRef Full Text | Google Scholar Behavioral Assessment of Acute Inhibition of System Xc (-) in Rats PubMed Abstract | CrossRef Full Text | Google Scholar Xc- Inhibitor Sulfasalazine Sensitizes Colorectal Cancer to Cisplatin by a GSH-dependent Mechanism PubMed Abstract | CrossRef Full Text | Google Scholar Main Path and Byways: Non-vesicular Glutamate Release by System Xc(-) as an Important Modifier of Glutamatergic Neurotransmission PubMed Abstract | CrossRef Full Text | Google Scholar Dopaminergic Neurons of System X(c)(-)-Deficient Mice Are Highly Protected against 6-Hydroxydopamine-Induced Toxicity PubMed Abstract | CrossRef Full Text | Google Scholar Inhibition of Type 4 cAMP-Phosphodiesterases (PDE4s) in Mice Induces Hypothermia via Effects on Behavioral and Central Autonomous Thermoregulation PubMed Abstract | CrossRef Full Text | Google Scholar Excitotoxicity: Bridge to Various Triggers in Neurodegenerative Disorders PubMed Abstract | CrossRef Full Text | Google Scholar System xC- Is a Mediator of Microglial Function and its Deletion Slows Symptoms in Amyotrophic Lateral Sclerosis Mice PubMed Abstract | CrossRef Full Text | Google Scholar Possible Involvement of Prostaglandins in Psychological Stress-Induced Responses in Rats PubMed Abstract | CrossRef Full Text | Google Scholar Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel Target for Cancer-Induced Depression System X(c)(-) Antiporter Inhibitors: Azo-Linked Amino-Naphthyl-Sulfonate Analogues of Sulfasalazine PubMed Abstract | CrossRef Full Text | Google Scholar Underlying Mechanism for NMDA Receptor Antagonism by the Anti-inflammatory Drug PubMed Abstract | CrossRef Full Text | Google Scholar The Mayo Clinic-Canadian Cooperative Trial of Sulfasalazine in Active Multiple Sclerosis PubMed Abstract | CrossRef Full Text | Google Scholar Stress-induced Hyperthermia and Hypothermia CrossRef Full Text | Google Scholar Stress-induced Hyperthermia and Anxiety: Pharmacological Validation PubMed Abstract | CrossRef Full Text | Google Scholar Excitotoxicity in the Pathogenesis of Neurological and Psychiatric Disorders: Therapeutic Implications CrossRef Full Text | Google Scholar Induces Prostaglandin-Mediated Hyperthermia in Pigs PubMed Abstract | CrossRef Full Text | Google Scholar Patel, D., Kharkar, P. S., Gandhi, N. S., Kaur, E., Dutt, S., and Nandave, M. (2019). Novel Analogs of Sulfasalazine as System Xc− Antiporter Inhibitors: Insights from the Molecular Modeling Studies. Drug Development Res. 80 (6), 758–777. 10.1002/ddr.21557 PubMed Abstract | CrossRef Full Text | Google Scholar PubMed Abstract | CrossRef Full Text | Google Scholar Suppression of Experimental Autoimmune Encephalomyelitis by Sulfasalazine PubMed Abstract | CrossRef Full Text | Google Scholar and anti-IL-12/23p40 in a TNBS-Induced Crohn's Disease Model PubMed Abstract | CrossRef Full Text | Google Scholar A Review of its Pharmacological Properties and Therapeutic Efficacy in the Treatment of Rheumatoid Arthritis PubMed Abstract | CrossRef Full Text | Google Scholar Randomized Study of Sulfasalazine for the Treatment of Progressing Malignant Gliomas in Adults PubMed Abstract | CrossRef Full Text | Google Scholar Ethopharmacological Analysis of the Effects of Putative 'anxiogenic' Agents in the Mouse Elevated Plus-Maze PubMed Abstract | CrossRef Full Text | Google Scholar The Novel Neuroprotective Action of Sulfasalazine through Blockade of NMDA Receptors PubMed Abstract | CrossRef Full Text | Google Scholar Redox Imbalance in Cystine/glutamate Transporter-Deficient Mice PubMed Abstract | CrossRef Full Text | Google Scholar Comparative Evaluation between Sulfasalazine Alone and in Combination with Herbal Medicine on DSS-Induced Ulcerative Colitis Mice PubMed Abstract | CrossRef Full Text | Google Scholar Dose-escalation Study for the Targeting of CD44v(+) Cancer Stem Cells by Sulfasalazine in Patients with Advanced Gastric Cancer (EPOC1205) PubMed Abstract | CrossRef Full Text | Google Scholar Pharmacokinetics of Salazosulfapyridine (Sulfasalazine SASP) (I):Plasma Kinetics and Plasma Metabolites in the Rat After a Single Intravenous or Oral Administration The Possible Ameliorative Effect of Simvastatin versus Sulfasalazine on Acetic Acid Induced Ulcerative Colitis in Adult Rats PubMed Abstract | CrossRef Full Text | Google Scholar PubMed Abstract | CrossRef Full Text | Google Scholar Cystine/glutamate Antiporter Blockage Induces Myelin Degeneration PubMed Abstract | CrossRef Full Text | Google Scholar A Hitchhiker's Guide to Behavioral Analysis in Laboratory Rodents CrossRef Full Text | Google Scholar The Tail Suspension Test: a New Method for Screening Antidepressants in Mice PubMed Abstract | CrossRef Full Text | Google Scholar Sulfasalazine and Temozolomide with Radiation Therapy for Newly Diagnosed Glioblastoma PubMed Abstract | CrossRef Full Text | Google Scholar Inhibition of Breast Cancer-Cell Glutamate Release with Sulfasalazine Limits Cancer-Induced Bone Pain PubMed Abstract | CrossRef Full Text | Google Scholar High Expression of CD44v9 and xCT in Chemoresistant Hepatocellular Carcinoma: Potential Targets by Sulfasalazine PubMed Abstract | CrossRef Full Text | Google Scholar Suppression of NF-kappaB Activity by Sulfasalazine Is Mediated by Direct Inhibition of IkappaB Kinases Alpha and Beta PubMed Abstract | CrossRef Full Text | Google Scholar Targeted Exosome-Encapsulated Erastin Induced Ferroptosis in Triple Negative Breast Cancer Cells PubMed Abstract | CrossRef Full Text | Google Scholar Toxicokinetics of Sulfasalazine (Salicylazosulfapyridine) and its Metabolites in B6C3F1 Mice Google Scholar Nicaise C and Massie A (2021) Chronic Sulfasalazine Treatment in Mice Induces System xc− - Independent Adverse Effects Received: 03 November 2020; Accepted: 26 April 2021;Published: 18 May 2021 Copyright © 2021 Verbruggen, Sprimont, Bentea, Janssen, Gharib, Deneyer, De Pauw, Lara, Sato, Nicaise and Massie. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use distribution or reproduction in other forums is permitted provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited in accordance with accepted academic practice distribution or reproduction is permitted which does not comply with these terms *Correspondence: Ann Massie, YW5uLm1hc3NpZUB2dWIuYmU= Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. 94% of researchers rate our articles as excellent or goodLearn more about the work of our research integrity team to safeguard the quality of each article we publish. Strong/MDI Screen Systems has announced a cooperative agreement with Lemmens S.A., located in Sprimont, Belgium, to facilitate expedited screen shipments for cinema industry customers in Europe and the Middle East. The new agreement will utilize Lemmens’ facility and Strong/MDI’s proprietary screen manufacturing processes to facilitate quick-ship screen deliveries to cinema operators in Europe and the Middle East. Customers with requirements for urgent screen deliveries will be able to receive shipments in less than ten days from the new quick-ship program, which is expected to be on-line and operational by June 1, 2022. “We are delighted with this new collaboration, which we believe will greatly reduce waiting and delivery times for urgent screen orders for clients in Europe and the Middle East,” said François Barrette, senior vice president & general manager for STRONG/MDI. “In helping to eliminate unnecessary delays, we see this agreement as highly beneficial to our valued customers in these expanding exhibition sectors.” “We have searched long and hard over the past couple of years for the right solution to provide our exhibitors in Europe and the Middle East with Strong/MDI screens through an expedited quick-ship program. We now have the answer with our new partnership with Lemmens in Belgium,” said President of STRONG/MDI, Ray Boegner. “We’re happy to be working with Strong/MDI in this arrangement that will allow us to develop a new division within our company and apply our years of experience in processing and delivering quality products throughout the regions we service and beyond!” stated Mr. Francy Lemmens, managing director of Lemmens S.A. “Our entire team is looking forward to working with Strong/MDI to provide this valuable service to our customers in the EMEA market.” Fandango and Imax have announced a partnership with Blast, which creates live and digital esports experiences, to bring the Fortnite Championship Pro-Am 2025 to select Imax screens at AMC Theatres across the United States on May 10, 2025. Broadcast live... Warner Bros. Pictures’ critical and commercial hit Sinners, the latest from filmmaker Ryan Coogler, will be re-released in nine select IMAX 70mm theaters across North America. Tickets are on sale now for screenings taking place from Thursday, May 15th to... Tickets are on sale now for Academy Award-winning director Hayao Miyazaki’s Kiki’s Delivery Service—the beloved coming-of-age story of a resourceful young witch who uses her broom to create a delivery service. The film returns to theaters this May for five... Following its February kickoff in Seoul and spanning across North America and Asia, j-hope’s first solo world tour, Hope on the Stage, has entertained audiences in 15 regions with 31 concerts. The grand finale of the tour will be broadcast... DISCLAIMER: The currency conversion is provided for illustration purposes only. It is meant only as an approximation based on the latest information available and should not be relied upon for any other purposes. We are not responsible for any loss that you may incur as a result of relying on these currency conversions. All property prices are as stated by the listing agent. By continuing to use this website, you agree to the use of cookies in order to offer you content and services that are tailored to your interests. fled Chechnya when his brother discovered his homosexuality and promised to kill him The only link that he keeps with Chechnya are the vocal messages that his mother sends him The film traces Khavaj’s first months in Belgium Forced to live in total anonymity to escape the Chechnyan diaspora International Documentary Festival - FIPADOCFrance IDFA - International Documentary Film Festival AmsterdamThe Netherlands as well as representatives based in the U.S The organisation currently brings together more than 1,000 French cinema and TV content professionals (producers etc.) working together to promote French films and TV programmes among foreign audiences Bannaux, Belgium (AINA) -- On August 4, 2013 hundreds of Assyrians (also known as Chaldeans and Syriacs) and their friends from all over Europe gathered at the site of the Bannaux Sanctuary in the municipality of Sprimont/Belgium. At the heart of Europe people came together to unveil a monument commemorating the Assyrian victims of the genocide of 1915 perpetrated by the former Ottoman State (AINA 8-5-2013) With the 100th anniversary of the Turkish genocide of Assyrians, Armenians and Greeks approaching, this latest genocide monument is the seventh Assyrian monument to be erected since 2000. Assyrian genocide monuments have been erected in Australia the mother of God appeared to an 11 year old girl called Mariette Since then the place holds a shrine and has emerged as one of the most popular Catholic pilgrimage sites in Europe known as "Our Lady of Bannaux." Bannaux is a small hamlet just southeast of Liège and 50 miles east of Brussels in French-speaking Belgium The Shrine of the Virgin of the Poor includes the 'Sacred Spring' several small chapels throughout the forest a hospital for the sick who come for healing and a pilgrim's information office The monument was erected thanks to the effort and diligence of the leading members of the Syriaque-Institute of Belgium, which also represents the Assyrian Genocide Research Center in Europe where an Assyrian Genocide monument has been erected in a public space The ceremony started at 2pm at the Sacred Spring and was led by dignitaries and a childrens' choir chanting church songs After the crowd of hundreds of people arrived at the site of the monument people took seats in a glade surrounded by trees; the almost two and half meter high stone was positioned between two trees and veiled with black satin The unvealing ceremony began after a short welcome by the moderators of the day Belgian Federal Parliament Deputy and Melke Gabriel The unveiling was accompanied by the cheers and shouts of joy from the audience The blessing ceremony of the monument was conducted by H.E and followed by prayers and chants attended by Bishop Aloys Jousten abbot Leo Palm and many other church representatives of the Syriac Catholic Church the Assyrian Church of the East and the Russian Orthodox Church of Liège The text engraved in two languages (French and Syriac) on the monument reads: pray for Assyrian (Syriac) Martyrs of Seyfo genocide perpetrated by the Ottoman Empire in 1915 and relieve the suffering of their children Fatrus Gabriel from the Syriac Institute of Belgium said that "this is a monument for peace The artist has carved a dove into the stone as symbol of peace to commemorate our martyrs we also let two white doves fly to symbolize peace We do not blame the Turks as a people for the genocide We have many friends among them who are also present today We hope that this monument contributes to the process of recognition of the Assyrian Genocide Although the pain has been passed down from generation to generation it may heal slowly so that peace is restored between the people concerned." the director of the Assyrian Genocide Research Center made a call on the leaders of the Turkish state to stop their denial policy He stressed that "the Republic of Turkey was built upon the systematic ethnic cleansing of Assyrians The Ottoman Empire is responsible for the physical annihilation of 1.5 million Armenians 750,000 Assyrians and 500,000 Pontic Greeks." He mentioned that similar monuments have already been erected in Australia France and Armenia and a next one is due in Athens Van and Istanbul will host such stumbling stones," he added Atman also criticized the efforts of the Turkish Embassy in Brussels which sent threatening letters to Assyrian clerics and associations denying that such a thing as the genocide happened in 1915 and demanding not to join the event Similar letters were apparently sent to Belgian officials as one of the oldest people in the Middle-East The Turkish state needs to confront this injustice." The Prime Minister was represented by Marie-Dominique Simonet former Minister of Education of the Federation Wallonie-Bruxelles both expressing their support for the Assyrian community of Belgium and the need for recognition of the genocide by the Belgian State The MP Benoit Dreze endorsed the proposal in the presence of Mr President of CPAS (Centres Publics d'Action Sociale) and magistrate of Social Affairs of the community of Sprimont The mayor of Sprimont was represented by Emanuel Padoux emphasizing the importance of such a monument and expressing joy to host it Zalgai Aho appeared and delivered a message of sympathy She is the daughter of the Assyrian poet and national activist Ninos Aho who was in recent years a messenger for the recognition of the genocide was supposed to be present at this unveiling event Bannaux Zalgai Aho expressed gratitude for the organizers and particularly the artist for carving the title of a famous poem of her beloved father on the monument the official ceremony was enriched by the presence and messages delivered by several delegates of Assyrian political and civil organizations from Germany To mention are delegations from Assyrian national organizations in Europe (among them the Assyrian Democratic Organization the Assyrian Universal Alliance and the European Syriac Union) and Assyrian Federations from Sweden clerics from various churches as well as Armenian Kurdish and Turkish guests attended and delivered messages of solidarity at the ceremony All speakers repeated the appeal to the Turkish government to face its tragic history and requested recognition and apology for the crimes committed against its Christian population in 1915 According to the invitation (see below) the event was sponsored by more than a dozen Assyrian organizations including the Inanna Foundation and the Yoken-bar-Yoken Foundation The ceremony ended with acknowledgements of the organizers to all those participating as well as all those excused (among them Archbishop Philoxenus Mattias Nayis) which sent their solidarity messages in writing supporting the recognition of the Assyrian genocide He has published numerous articles on the situation of the Assyrians in the Middle East In an international human rights tribunal in 1987 judging on the minority issues in Turkey he represented Assyrian organizations and presented the Assyrian Genocide to the public The tribunal was led by the Society for Endangered People Currently he is Chairman of the board of trustees of the Yoken-bar-Yoken Foundation and Board member of the Mor Afrem Foundation Miryam Abraham is a Bachelor student in Governance and Public Policy at the University of Passau The Local Europe ABVästmannagatan 43113 25 StockholmSweden Please log in here to leave a comment This website is using a security service to protect itself from online attacks The action you just performed triggered the security solution There are several actions that could trigger this block including submitting a certain word or phrase You can email the site owner to let them know you were blocked Please include what you were doing when this page came up and the Cloudflare Ray ID found at the bottom of this page.